OLANZAPINE AND SAMIDORPHAN L-MALATE

OLANZAPINE AND SAMIDORPHAN L-MALATE was reported 1687 times

These side effects are most commonly reported by patients taking OLANZAPINE AND SAMIDORPHAN L-MALATE:

# Side effect Count
0 OFF LABEL USE 306
1 CONTRAINDICATED PRODUCT ADMINISTERED 139
2 WEIGHT INCREASED 91
3 DIZZINESS 89
4 DRUG WITHDRAWAL SYNDROME 77
5 INSOMNIA 76
6 NAUSEA 70
7 WEIGHT DECREASED 68
8 VOMITING 64
9 FEELING ABNORMAL 61
10 SOMNOLENCE 59
11 FATIGUE 56
12 SEDATION 56
13 DECREASED APPETITE 53
14 ANXIETY 50
15 HYPERSOMNIA 46
16 TREMOR 43
17 WITHDRAWAL SYNDROME 39
18 DRUG SCREEN FALSE POSITIVE 37
19 DRUG INEFFECTIVE 34
20 AGITATION 33
21 MALAISE 30
22 PSYCHOTIC DISORDER 30
23 CONFUSIONAL STATE 29
24 DIARRHOEA 24
25 DRUG INTERACTION 24
26 DRUG SCREEN POSITIVE 24
27 OEDEMA PERIPHERAL 24
28 SEIZURE 24
29 LETHARGY 23
30 RESTLESSNESS 23
31 CONSTIPATION 22
32 DEPRESSION 22
33 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22
34 GAIT DISTURBANCE 21
35 HALLUCINATION, AUDITORY 21
36 HOSPITALISATION 21
37 THERAPEUTIC RESPONSE UNEXPECTED 21
38 HYPERHIDROSIS 20
39 MANIA 20
40 SUICIDAL IDEATION 20
41 AGGRESSION 19
42 HALLUCINATION 19
43 HEADACHE 19
44 DYSPNOEA 18
45 FALL 18
46 HYPOAESTHESIA 18
47 INCREASED APPETITE 18
48 DRY MOUTH 17
49 EUPHORIC MOOD 17
50 PERIPHERAL SWELLING 16
51 ADVERSE DRUG REACTION 15
52 DEATH 15
53 MEMORY IMPAIRMENT 15
54 PAIN 15
55 RASH 15
56 ABDOMINAL DISCOMFORT 14
57 DISORIENTATION 14
58 MUSCLE SPASMS 14
59 NIGHTMARE 14
60 VISION BLURRED 14
61 BALANCE DISORDER 13
62 DYSARTHRIA 13
63 DYSKINESIA 13
64 MYALGIA 13
65 ASTHENIA 12
66 BLOOD GLUCOSE INCREASED 12
67 SCHIZOPHRENIA 12
68 SLEEP DISORDER 12
69 URINARY RETENTION 12
70 ANGER 11
71 CONDITION AGGRAVATED 11
72 ILLNESS 11
73 MUSCLE TWITCHING 11
74 MUSCULOSKELETAL STIFFNESS 11
75 PALPITATIONS 11
76 PARAESTHESIA 11
77 CEREBROVASCULAR ACCIDENT 10
78 DRUG INTOLERANCE 10
79 GASTROINTESTINAL DISORDER 10
80 LOSS OF CONSCIOUSNESS 10
81 PSYCHIATRIC DECOMPENSATION 10
82 SUBSTANCE USE 10
83 BRAIN FOG 9
84 HEPATIC ENZYME INCREASED 9
85 HYPERSENSITIVITY 9
86 MENTAL DISORDER 9
87 TARDIVE DYSKINESIA 9
88 THERAPEUTIC RESPONSE DECREASED 9
89 TREATMENT NONCOMPLIANCE 9
90 ABNORMAL BEHAVIOUR 8
91 COGNITIVE DISORDER 8
92 DELIRIUM 8
93 DELUSION 8
94 DISSOCIATION 8
95 DYSTONIA 8
96 ERYTHEMA 8
97 HYPOTENSION 8
98 IRRITABILITY 8
99 MUSCLE TIGHTNESS 8
100 NEUROLEPTIC MALIGNANT SYNDROME 8
101 PRESCRIBED OVERDOSE 8
102 PRURITUS 8
103 PYREXIA 8
104 SPEECH DISORDER 8
105 SWELLING FACE 8
106 URINARY INCONTINENCE 8
107 AKATHISIA 7
108 DEHYDRATION 7
109 ENERGY INCREASED 7
110 EXTRA DOSE ADMINISTERED 7
111 FEELING DRUNK 7
112 HYPERTENSION 7
113 MUSCULAR WEAKNESS 7
114 OEDEMA 7
115 PRODUCT DOSE OMISSION ISSUE 7
116 RESTLESS LEGS SYNDROME 7
117 SWELLING 7
118 VERTIGO 7
119 ABNORMAL DREAMS 6
120 BLOOD PRESSURE INCREASED 6
121 BLOOD TRIGLYCERIDES INCREASED 6
122 CHEST PAIN 6
123 CHILLS 6
124 DEPRESSED MOOD 6
125 DRUG DEPENDENCE 6
126 DYSPHAGIA 6
127 DYSURIA 6
128 EMOTIONAL DISTRESS 6
129 ERECTILE DYSFUNCTION 6
130 FEELING HOT 6
131 FEELING JITTERY 6
132 FLAT AFFECT 6
133 HALLUCINATION, VISUAL 6
134 MIDDLE INSOMNIA 6
135 OVERDOSE 6
136 PRODUCT USE ISSUE 6
137 THIRST 6
138 URINARY TRACT INFECTION 6
139 ABDOMINAL PAIN 5
140 ABDOMINAL PAIN UPPER 5
141 ALOPECIA 5
142 ARTHRALGIA 5
143 CARDIAC DISORDER 5
144 DISTURBANCE IN ATTENTION 5
145 DROOLING 5
146 DRUG ABUSE 5
147 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5
148 DYSPHEMIA 5
149 GASTROOESOPHAGEAL REFLUX DISEASE 5
150 GLYCOSYLATED HAEMOGLOBIN INCREASED 5
151 HEART RATE INCREASED 5
152 HUNGER 5
153 IMPAIRED DRIVING ABILITY 5
154 INTENTIONAL OVERDOSE 5
155 INTENTIONAL PRODUCT MISUSE 5
156 MENTAL IMPAIRMENT 5
157 MOOD SWINGS 5
158 NASOPHARYNGITIS 5
159 NERVOUSNESS 5
160 PAIN IN EXTREMITY 5
161 PANIC ATTACK 5
162 PRODUCT PRESCRIBING ISSUE 5
163 PSYCHIATRIC SYMPTOM 5
164 RHABDOMYOLYSIS 5
165 SEXUAL DYSFUNCTION 5
166 SOMNAMBULISM 5
167 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 5
168 TINNITUS 5
169 ACUTE KIDNEY INJURY 4
170 ANAPHYLACTIC REACTION 4
171 COMA 4
172 COMPLETED SUICIDE 4
173 DIABETES MELLITUS 4
174 DIPLOPIA 4
175 DISCOMFORT 4
176 DRUG EFFECT LESS THAN EXPECTED 4
177 ENURESIS 4
178 GENERALISED OEDEMA 4
179 HANGOVER 4
180 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
181 INFLUENZA LIKE ILLNESS 4
182 INTENTIONAL UNDERDOSE 4
183 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4
184 LOW DENSITY LIPOPROTEIN INCREASED 4
185 MENSTRUATION IRREGULAR 4
186 MIGRAINE 4
187 MOOD ALTERED 4
188 PNEUMONIA 4
189 POLLAKIURIA 4
190 PRODUCT PRESCRIBING ERROR 4
191 PRODUCT USE IN UNAPPROVED INDICATION 4
192 PSYCHOTIC SYMPTOM 4
193 PULMONARY EMBOLISM 4
194 ROAD TRAFFIC ACCIDENT 4
195 SEPSIS 4
196 SLEEP APNOEA SYNDROME 4
197 SURGERY 4
198 SWOLLEN TONGUE 4
199 THROMBOSIS 4
200 TIC 4
201 TREATMENT FAILURE 4
202 UNEVALUABLE EVENT 4
203 UNRESPONSIVE TO STIMULI 4
204 ACCIDENTAL OVERDOSE 3
205 AFFECTIVE DISORDER 3
206 AMNESIA 3
207 APATHY 3
208 BACK PAIN 3
209 BINGE EATING 3
210 BLOOD CREATINE PHOSPHOKINASE INCREASED 3
211 BLOOD GLUCOSE DECREASED 3
212 BURNING SENSATION 3
213 CATATONIA 3
214 CLUMSINESS 3
215 COUGH 3
216 DIABETIC KETOACIDOSIS 3
217 DRUG SCREEN NEGATIVE 3
218 EMOTIONAL DISORDER 3
219 ERECTION INCREASED 3
220 FLUID RETENTION 3
221 FLUSHING 3
222 FOOD CRAVING 3
223 GLUCOSE TOLERANCE IMPAIRED 3
224 HEAT STROKE 3
225 HEAVY MENSTRUAL BLEEDING 3
226 HOT FLUSH 3
227 IMPULSIVE BEHAVIOUR 3
228 INADEQUATE ANALGESIA 3
229 INCOHERENT 3
230 INTENTIONAL PRODUCT USE ISSUE 3
231 INTENTIONAL SELF-INJURY 3
232 JOINT SWELLING 3
233 LIVER FUNCTION TEST INCREASED 3
234 MAJOR DEPRESSION 3
235 MENTAL STATUS CHANGES 3
236 MOTOR DYSFUNCTION 3
237 MUSCLE RIGIDITY 3
238 MYDRIASIS 3
239 NEAR DEATH EXPERIENCE 3
240 NECK PAIN 3
241 NIGHT SWEATS 3
242 PARANOIA 3
243 PARKINSONISM 3
244 PERIORBITAL SWELLING 3
245 PRODUCT DOSE OMISSION IN ERROR 3
246 SEASONAL ALLERGY 3
247 SEDATION COMPLICATION 3
248 SLEEP PARALYSIS 3
249 SLUGGISHNESS 3
250 SUICIDE ATTEMPT 3
251 SYNCOPE 3
252 TEMPERATURE REGULATION DISORDER 3
253 THERAPY CESSATION 3
254 THINKING ABNORMAL 3
255 THROAT TIGHTNESS 3
256 TOXIC ENCEPHALOPATHY 3
257 UPPER LIMB FRACTURE 3
258 WEIGHT FLUCTUATION 3
259 ACTIVITIES OF DAILY LIVING DECREASED 2
260 ACUTE OESOPHAGEAL MUCOSAL LESION 2
261 ALCOHOL INTERACTION 2
262 ALCOHOLISM 2
263 ALLERGIC COUGH 2
264 AMENORRHOEA 2
265 ANAL INCONTINENCE 2
266 ANHEDONIA 2
267 APHASIA 2
268 ATAXIA 2
269 ATRIAL FIBRILLATION 2
270 AUTOSCOPY 2
271 BACK INJURY 2
272 BIPOLAR DISORDER 2
273 BIPOLAR I DISORDER 2
274 BLEPHAROSPASM 2
275 BLOOD CHOLESTEROL INCREASED 2
276 BLOOD GLUCOSE FLUCTUATION 2
277 BLOOD PRESSURE ABNORMAL 2
278 BLOOD SODIUM DECREASED 2
279 BODY TEMPERATURE INCREASED 2
280 BRADYCARDIA 2
281 CARDIAC ARREST 2
282 CARDIAC FAILURE 2
283 CEREBRAL HAEMORRHAGE 2
284 CLUSTER HEADACHE 2
285 COORDINATION ABNORMAL 2
286 CORNEAL ABRASION 2
287 CORONAVIRUS INFECTION 2
288 DECREASED ACTIVITY 2
289 DISTURBANCE IN SOCIAL BEHAVIOUR 2
290 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2
291 DRUG HYPERSENSITIVITY 2
292 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2
293 DRUG USE DISORDER 2
294 DYSPHONIA 2
295 DYSPHORIA 2
296 DYSSTASIA 2
297 ECZEMA 2
298 ELECTROLYTE IMBALANCE 2
299 EMOTIONAL POVERTY 2
300 ENCEPHALOPATHY 2
301 ENDOTRACHEAL INTUBATION 2
302 EPISTAXIS 2
303 EXPIRED PRODUCT ADMINISTERED 2
304 EXPOSURE TO FUNGUS 2
305 EXTRAPYRAMIDAL DISORDER 2
306 FACIAL PARALYSIS 2
307 FALLOPIAN TUBE CANCER 2
308 FINE MOTOR SKILL DYSFUNCTION 2
309 FORMICATION 2
310 FRACTURED COCCYX 2
311 GAIT INABILITY 2
312 GASTRIC DISORDER 2
313 GASTRIC ULCER 2
314 GRIP STRENGTH DECREASED 2
315 HAEMATEMESIS 2
316 HEPATIC FAILURE 2
317 HEPATIC PAIN 2
318 HIP ARTHROPLASTY 2
319 HYPERPHAGIA 2
320 HYPERVIGILANCE 2
321 HYPOKINESIA 2
322 HYPOMANIA 2
323 INCORRECT DOSE ADMINISTERED 2
324 INFLAMMATION 2
325 INJECTION SITE PAIN 2
326 LACRIMATION INCREASED 2
327 LIBIDO DECREASED 2
328 LIBIDO DISORDER 2
329 LIP DRY 2
330 MATERNAL EXPOSURE DURING PREGNANCY 2
331 MECHANICAL VENTILATION 2
332 MENSTRUATION DELAYED 2
333 MOBILITY DECREASED 2
334 MOVEMENT DISORDER 2
335 MUSCLE ATROPHY 2
336 MUSCLE CONTRACTIONS INVOLUNTARY 2
337 NASAL CONGESTION 2
338 NO ADVERSE EVENT 2
339 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2
340 OCULOGYRIC CRISIS 2
341 OESOPHAGEAL HAEMORRHAGE 2
342 OESOPHAGEAL INJURY 2
343 OESOPHAGEAL ULCER 2
344 OVARIAN CANCER 2
345 PANCYTOPENIA 2
346 PERSONALITY CHANGE 2
347 PETIT MAL EPILEPSY 2
348 PHARYNGEAL SWELLING 2
349 PHOTOPSIA 2
350 PHOTOSENSITIVITY REACTION 2
351 PNEUMOTHORAX 2
352 POLYDIPSIA 2
353 POOR QUALITY SLEEP 2
354 PRODUCT ADMINISTRATION INTERRUPTED 2
355 PRODUCT COLOUR ISSUE 2
356 PRODUCT COMMUNICATION ISSUE 2
357 PRODUCT DISPENSING ISSUE 2
358 PRODUCT DISTRIBUTION ISSUE 2
359 PRODUCT PACKAGING QUANTITY ISSUE 2
360 PSEUDOSTROKE 2
361 PSYCHOMOTOR HYPERACTIVITY 2
362 RESPIRATORY ARREST 2
363 SCOLIOSIS 2
364 SINUS TACHYCARDIA 2
365 SLEEP TERROR 2
366 SLOW SPEECH 2
367 STRESS 2
368 SUBSTANCE ABUSE 2
369 TACHYCARDIA 2
370 TACHYPHRENIA 2
371 THERAPEUTIC PRODUCT EFFECT DECREASED 2
372 THERAPY CHANGE 2
373 THERMAL BURN 2
374 THROMBOCYTOPENIA 2
375 TONGUE BITING 2
376 TONGUE MOVEMENT DISTURBANCE 2
377 TOOTH DISORDER 2
378 TOOTH INFECTION 2
379 TOXICITY TO VARIOUS AGENTS 2
380 TRANSIENT ISCHAEMIC ATTACK 2
381 TRISMUS 2
382 VICTIM OF SEXUAL ABUSE 2
383 VISUAL IMPAIRMENT 2
384 WEIGHT ABNORMAL 2
385 ABNORMAL FAECES 1
386 ACCIDENT 1
387 ACNE 1
388 ACUTE PSYCHOSIS 1
389 ADVERSE EVENT 1
390 ADVERSE REACTION 1
391 AGEUSIA 1
392 ALANINE AMINOTRANSFERASE INCREASED 1
393 ALCOHOL USE 1
394 ALCOHOL WITHDRAWAL SYNDROME 1
395 ALLODYNIA 1
396 ANAEMIA 1
397 ANAESTHESIA PROCEDURE 1
398 ANHIDROSIS 1
399 ANKLE FRACTURE 1
400 ANKYLOSING SPONDYLITIS 1
401 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1
402 ARRHYTHMIA 1
403 ARTHRITIS 1
404 ASPARTATE AMINOTRANSFERASE INCREASED 1
405 ATHETOSIS 1
406 AUDITORY DISORDER 1
407 AURA 1
408 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1
409 BACK DISORDER 1
410 BEDRIDDEN 1
411 BEHAVIOUR DISORDER 1
412 BINGE DRINKING 1
413 BLINDNESS 1
414 BLISTER 1
415 BLOOD ALBUMIN DECREASED 1
416 BLOOD BILIRUBIN INCREASED 1
417 BLOOD CALCIUM DECREASED 1
418 BLOOD ELECTROLYTES DECREASED 1
419 BLOOD GLUCOSE ABNORMAL 1
420 BLOOD INSULIN INCREASED 1
421 BLOOD LACTIC ACID DECREASED 1
422 BLOOD MAGNESIUM DECREASED 1
423 BLOOD PHOSPHORUS INCREASED 1
424 BLOOD POTASSIUM DECREASED 1
425 BLOOD PRESSURE FLUCTUATION 1
426 BLOOD PROLACTIN INCREASED 1
427 BLOOD THYROID STIMULATING HORMONE INCREASED 1
428 BODY MASS INDEX INCREASED 1
429 BONE DENSITY ABNORMAL 1
430 BOWEL MOVEMENT IRREGULARITY 1
431 BRADYKINESIA 1
432 CACHEXIA 1
433 CARBON DIOXIDE DECREASED 1
434 CHAPPED LIPS 1
435 CHEST DISCOMFORT 1
436 CHROMATURIA 1
437 CLINODACTYLY 1
438 COLD SWEAT 1
439 COLITIS 1
440 COLITIS ULCERATIVE 1
441 COLOUR BLINDNESS 1
442 CONFUSIONAL AROUSAL 1
443 CONTRAINDICATED PRODUCT PRESCRIBED 1
444 CONTUSION 1
445 COVID-19 1
446 CREATINE KINASE INCREASED 1
447 CREPITATIONS 1
448 CRYING 1
449 DARK CIRCLES UNDER EYES 1
450 DEAFNESS 1
451 DECREASED INTEREST 1
452 DEJA VU 1
453 DELUSIONAL PERCEPTION 1
454 DENTAL CARIES 1
455 DEPENDENCE 1
456 DEPERSONALISATION/DEREALISATION DISORDER 1
457 DEPRESSED LEVEL OF CONSCIOUSNESS 1
458 DEPRESSIVE SYMPTOM 1
459 DEREALISATION 1
460 DERMATITIS 1
461 DIABETES MELLITUS INADEQUATE CONTROL 1
462 DIABETIC RETINAL OEDEMA 1
463 DISORGANISED SPEECH 1
464 DISTURBANCE IN SEXUAL AROUSAL 1
465 DIZZINESS POSTURAL 1
466 DREAMY STATE 1
467 DRUG EFFECT FASTER THAN EXPECTED 1
468 DRUG LEVEL ABOVE THERAPEUTIC 1
469 DRUG MONITORING PROCEDURE NOT PERFORMED 1
470 DRUG TITRATION ERROR 1
471 DRUG TOLERANCE DECREASED 1
472 DRUG WITHDRAWAL CONVULSIONS 1
473 DRY EYE 1
474 DUPLICATE THERAPY ERROR 1
475 DYSGEUSIA 1
476 DYSGRAPHIA 1
477 DYSPEPSIA 1
478 DYSPNOEA EXERTIONAL 1
479 EAR INFECTION 1
480 EARLY SATIETY 1
481 EATING DISORDER 1
482 EJACULATION FAILURE 1
483 ELECTRIC SHOCK SENSATION 1
484 ENDODONTIC PROCEDURE 1
485 EXCESSIVE EYE BLINKING 1
486 EXOPHTHALMOS 1
487 EXPOSURE VIA BREAST MILK 1
488 EXTRAOCULAR MUSCLE DISORDER 1
489 EYE MOVEMENT DISORDER 1
490 EYE PAIN 1
491 EYE SWELLING 1
492 FACIAL ASYMMETRY 1
493 FEAR 1
494 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1
495 FEELING COLD 1
496 FEELING OF BODY TEMPERATURE CHANGE 1
497 FEELING OF RELAXATION 1
498 FEMALE ORGASMIC DISORDER 1
499 FIBRIN D DIMER INCREASED 1
500 FOOD ALLERGY 1
501 FOOD AVERSION 1
502 FOOD POISONING 1
503 FRACTURE 1
504 GALACTORRHOEA 1
505 GASTRIC BYPASS 1
506 GASTROENTERITIS 1
507 GASTROINTESTINAL INFLAMMATION 1
508 GASTROINTESTINAL OBSTRUCTION 1
509 GASTROINTESTINAL PAIN 1
510 GENITAL BURNING SENSATION 1
511 GLYCOSYLATED HAEMOGLOBIN DECREASED 1
512 HAEMATOCRIT INCREASED 1
513 HAEMODYNAMIC INSTABILITY 1
514 HAEMOGLOBIN INCREASED 1
515 HAEMORRHAGIC STROKE 1
516 HAEMORRHOIDS 1
517 HALLUCINATION, TACTILE 1
518 HEAD INJURY 1
519 HEART RATE IRREGULAR 1
520 HEPATIC CIRRHOSIS 1
521 HEPATIC STEATOSIS 1
522 HIATUS HERNIA 1
523 HUMERUS FRACTURE 1
524 HYPERAESTHESIA 1
525 HYPERGLYCAEMIA 1
526 HYPERPYREXIA 1
527 HYPERTENSIVE CRISIS 1
528 HYPERTHERMIA 1
529 HYPNAGOGIC HALLUCINATION 1
530 HYPNOPOMPIC HALLUCINATION 1
531 HYPOACUSIS 1
532 HYPOAESTHESIA ORAL 1
533 HYPOPHAGIA 1
534 HYPOTHERMIA 1
535 HYPOXIA 1
536 ILEUS PARALYTIC 1
537 IMPAIRED GASTRIC EMPTYING 1
538 IMPAIRED WORK ABILITY 1
539 INAPPROPRIATE AFFECT 1
540 INCONTINENCE 1
541 INCREASED NEED FOR SLEEP 1
542 INFECTION 1
543 INJURY 1
544 INTENTIONAL DOSE OMISSION 1
545 INTERCEPTED PRODUCT PRESCRIBING ERROR 1
546 IRREGULAR BREATHING 1
547 JAUNDICE 1
548 JOINT INSTABILITY 1
549 JOINT STIFFNESS 1
550 LABELLED DRUG-DRUG INTERACTION ISSUE 1
551 LAZINESS 1
552 LIP SWELLING 1
553 LIVER DISORDER 1
554 LIVER INJURY 1
555 LOCALISED OEDEMA 1
556 MALIGNANT HYPERTENSION 1
557 METABOLIC DISORDER 1
558 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 1
559 METABOLIC ENCEPHALOPATHY 1
560 METABOLIC SURGERY 1
561 MICTURITION URGENCY 1
562 MOUTH INJURY 1
563 MUSCULOSKELETAL DISCOMFORT 1
564 MYOCARDIAL NECROSIS MARKER INCREASED 1
565 MYOCLONUS 1
566 NARCOLEPSY 1
567 NASAL DISCOMFORT 1
568 NEEDLE ISSUE 1
569 NEGATIVE THOUGHTS 1
570 NEGLECT OF PERSONAL APPEARANCE 1
571 NEOPLASM 1
572 NEPHROLITHIASIS 1
573 NONSPECIFIC REACTION 1
574 NYSTAGMUS 1
575 OBSESSIVE THOUGHTS 1
576 OCULAR HYPERAEMIA 1
577 OESOPHAGEAL DISORDER 1
578 OESOPHAGEAL MOTILITY DISORDER 1
579 OESOPHAGEAL PAIN 1
580 OESOPHAGEAL SPASM 1
581 OESOPHAGOGASTRIC FUNDOPLASTY 1
582 OPTIC ISCHAEMIC NEUROPATHY 1
583 ORAL PAIN 1
584 ORTHOPAEDIC PROCEDURE 1
585 ORTHOSTATIC HYPOTENSION 1
586 OVERWORK 1
587 OXYGEN SATURATION DECREASED 1
588 PAIN OF SKIN 1
589 PALLOR 1
590 PANIC DISORDER 1
591 PANIC REACTION 1
592 PARAESTHESIA ORAL 1
593 PAROSMIA 1
594 PERSONALITY DISORDER 1
595 PNEUMONIA ASPIRATION 1
596 POISONING 1
597 POLYURIA 1
598 POOR PERSONAL HYGIENE 1
599 POST-TRAUMATIC STRESS DISORDER 1
600 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1
601 PREGNANCY 1
602 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1
603 PROCEDURAL NAUSEA 1
604 PRODUCT AVAILABILITY ISSUE 1
605 PRODUCT COMPLAINT 1
606 PRODUCT DISPENSING ERROR 1
607 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1
608 PRODUCT STORAGE ERROR 1
609 PRODUCT SUBSTITUTION ISSUE 1
610 PROSOPAGNOSIA 1
611 PULMONARY OEDEMA 1
612 PULPITIS DENTAL 1
613 RASH MACULAR 1
614 READING DISORDER 1
615 RED BLOOD CELL COUNT INCREASED 1
616 REFUSAL OF TREATMENT BY PATIENT 1
617 REHABILITATION THERAPY 1
618 RENAL FAILURE 1
619 RENAL IMPAIRMENT 1
620 RENAL PAIN 1
621 RESPIRATORY DISORDER 1
622 RESPIRATORY TRACT INFECTION 1
623 RESTLESS ARM SYNDROME 1
624 RHINORRHOEA 1
625 SALIVARY GLAND DISORDER 1
626 SCATOLIA 1
627 SCHIZOAFFECTIVE DISORDER 1
628 SCREAMING 1
629 SEIZURE CLUSTER 1
630 SEIZURE LIKE PHENOMENA 1
631 SELF-DESTRUCTIVE BEHAVIOUR 1
632 SELF-INJURIOUS IDEATION 1
633 SELF-MEDICATION 1
634 SENSORY DISTURBANCE 1
635 SEROTONIN SYNDROME 1
636 SHORT-BOWEL SYNDROME 1
637 SIALOADENITIS 1
638 SINUSITIS 1
639 SKIN BURNING SENSATION 1
640 SKIN DISORDER 1
641 SKIN EXFOLIATION 1
642 SKIN HAEMORRHAGE 1
643 SKIN INJURY 1
644 SKIN LACERATION 1
645 SKIN SWELLING 1
646 SKIN ULCER 1
647 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1
648 SLEEP-RELATED EATING DISORDER 1
649 SNORING 1
650 SOCIAL AVOIDANT BEHAVIOUR 1
651 SOCIAL PROBLEM 1
652 STEREOTYPY 1
653 STEVENS-JOHNSON SYNDROME 1
654 STILLBIRTH 1
655 STRESS AT WORK 1
656 SUPRAVENTRICULAR TACHYCARDIA 1
657 SUSPECTED COVID-19 1
658 SUSPECTED SUICIDE 1
659 SYRINGE ISSUE 1
660 TACHYPNOEA 1
661 TASTE DISORDER 1
662 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1
663 TESTICULAR PAIN 1
664 THERAPEUTIC PRODUCT EFFECT INCREASED 1
665 THERAPEUTIC RESPONSE INCREASED 1
666 THERAPEUTIC RESPONSE SHORTENED 1
667 TOBACCO INTERACTION 1
668 TOBACCO USER 1
669 TONGUE SPASM 1
670 TOOTH EXTRACTION 1
671 TORTICOLLIS 1
672 TOTAL CHOLESTEROL/HDL RATIO INCREASED 1
673 TRANCE 1
674 TROPONIN INCREASED 1
675 TYPE 2 DIABETES MELLITUS 1
676 UROSEPSIS 1
677 URTICARIA 1
678 VICTIM OF ABUSE 1
679 VIRAL UPPER RESPIRATORY TRACT INFECTION 1
680 VITREOUS FLOATERS 1
681 WAIST CIRCUMFERENCE DECREASED 1
682 WEIGHT GAIN POOR 1
683 WEIGHT LOSS POOR 1
684 WHEEZING 1
685 WHITE BLOOD CELL COUNT INCREASED 1
686 WRONG DOSE 1